FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.

  News   Mar 9, 2024   0   38  Add to Reading List
FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

INCREASE YOUR SALES WITH NGN1,000 TODAY!

Advertise on doacWeb

WhatsApp: 09031633831

To reach more people from NGN1,000 now!

INCREASE YOUR SALES WITH NGN1,000 TODAY!

Advertise on doacWeb

WhatsApp: 09031633831

To reach more people from NGN1,000 now!

INCREASE YOUR SALES WITH NGN1,000 TODAY!

Advertise on doacWeb

WhatsApp: 09031633831

To reach more people from NGN1,000 now!

This image provided by Novo Nordisk in January 2023 shows packaging for the company

The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, the FDA said.

Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow